Clinical trial
Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study
NCT06278909 is registered in ClinicalTrials.gov with Dr. Rafael Freire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study
- Lead sponsor
- Dr. Rafael Freire
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 18, 2024
- Completion date
- April 1, 2026
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.